Anthropic shares fall 11% in midmorning, nearing $83 IPO price
Key Facts
Anthropic shares fell 11% in midmorning trading on Friday, November 20, slipping below $87, Axios reported, on the company’s second day of trading on the market. The decline brought the stock closer to its initial public offering price of $83, after it began trading on Nasdaq on Thursday under the ticker ANT. The move followed the stock’s opening at $110.50 in the previous session and a peak of $115.10, according to Axios. Friday’s trading thus marked a sharp retreat from first-day levels, while the midmorning price cited remained above the offering price. The comparison is significant given the recent listing and the size of the offering the company closed that same day.
The 11% decline reported by Axios did not match the 12% figure in another report, and midmorning figures do not represent the session’s closing price. EL7 data showed that ANT closed at $97.17 a share on November 19, its first day of trading. The 11% figure refers specifically to midmorning trading on Friday, when the stock fell below $87, and does not establish the final closing level. The company’s shares opened Thursday at $110.50 before reaching $115.10, highlighting the wide gap between initial trading levels and the $83 offering price. These figures alone do not explain the price move as a technical correction or profit-taking.
Anthropic’s decline coincided with broader pressure on technology and AI stocks. Axios said the drop came alongside a steep fall in Nvidia shares, while the technology-heavy Nasdaq was down 2% at 10:31 a.m. Friday. The report linked the market move to investor pessimism toward the AI trade and concerns about the sustainability of spending on it. This context places Anthropic shares within a broader session of retreat from the sector, rather than showing a move isolated from the market. The report did not give a specific figure for Nvidia’s decline or quantify the spending that prompted the concerns.
Anthropic announced that it had closed its public offering on November 20, selling 1,127,000,000 Class A shares at $83 a share. The total included underwriters’ exercise in full of their option to purchase an additional 147,000,000 shares, according to the company’s statement. Gross proceeds from the offering were about $93.5 billion before discounts and expenses, while Anthropic received about $91.6 billion. Shares began trading on the Nasdaq Global Select Market on November 19 under the ticker ANT, one day before the company announced the offering’s close. The $83 price provides a direct benchmark for comparison with trading over the first two days, as the stock neared that level during Friday’s midmorning decline.
Anthropic warned in its prospectus filed with the U.S. Securities and Exchange Commission that an active market for its Class A shares might not develop, or might not continue if one did. It also said the offering price did not necessarily reflect the price at which investors would want to trade the shares after the listing. The warning comes as the stock neared its offering price after trading at higher levels on its first day, based on figures reported by Axios. Trading will depend on the extent to which demand continues in the market after the listing, while the prospectus does not guarantee that an active market will exist or persist. The disclosure provides direct context for the stock’s volatility in its first days on the public market.
Reuters quoted an analyst as saying the stock could remain volatile as listing enthusiasm fades and investors assess whether the high valuation can hold; he pointed to a valuation of about 40 times sales over the previous twelve months. It also quoted an investment official advising investors to wait until the company reports its public results. Separately, an analyst at index-rebalancing data firm Intropic estimated that index-tracking funds could buy as much as 30% of Anthropic shares by the end of 2026, a forecast that could provide support for the stock later. These figures remain forecasts attributed to the analysts and officials quoted by Reuters, not completed purchases or a confirmed date for the company’s results.